BRIEF-Resverlogix Corp announces dosing of first two patients in expanded renal and orphan programs

Thu Jul 21, 2016 7:37pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 21 (Reuters) - Resverlogix Corp :

* Results are expected in second half of 2016 from phase 1 study

* Resverlogix announces dosing of first two patients in expanded renal and orphan programs

Source text for Eikon:

Further company coverage: (Reporting by Parikshit Mishra)